International Journal of Reproductive BioMedicine (IJRM) · 2016 · 31 citations · 35 references
MedicineEndocrinologyGynecologyComparative EndocrinologyMetabolic RegulationReproductive EndocrinologyGynecologic EndocrinologyInsulin ResistanceMetabolic EndocrinologyMetabolic SyndromeOvarian DisordersPolycystic Ovary SyndromeEndocrine-related Metabolic DisordersInsulin Resistance AssessmentInsulin Resistance SyndromeObesity-associated Insulin ResistancePolycystic Ovary Syndrome ComorbidityPolycystic Ovary Syndrome-associated Insulin ResistanceWaist Circumference MeasurementWaist-to-hip Ratio
BACKGROUND: Insulin resistance has an important role in pathophysiology of polycystic ovarian syndrome (PCOS). Yet there are certain controversies regarding the presence of insulin resistance in non-obese patients. OBJECTIVE: The aim was to compare the insulin resistance and various endocrine and metabolic abnormalities in obese and non-obese PCOS women. MATERIALS AND METHODS: In this cross-sectional study which was performed from 2007-2010, 115 PCOS patients, aged 16-45 years were enrolled. Seventy patients were obese (BMI ≥25) and 45 patients were non-obese (BMI <25). Presence of insulin resistance and endocrine-metabolic abnormalities were compared between two groups. Collected data were analyzed with SPSS version 16.0 and p<0.05 was considered as statistically significant. RESULTS: There was no significant difference in presence of insulin resistance (HOMA-IR >2.3) between two groups (p=0.357). Waist circumference (p<0.001), waist/hip ratio (p<0.001), systolic (p<0.001) and diastolic (p<0.001) blood pressures, fasting blood sugar (p=0.003) and insulin (p=0.011), HOMA-IR (p=0.004), total cholesterol (p=0.001) and triglyceride (p<0.001) were all significantly higher in obese PCOS patients. There was no significant difference in total testosterone (p=0.634) and androstenedione (p=0.736) between groups whereas Dehydroepiandrotendione sulfate (DHEAS) was significantly higher in non-obese PCOS women (p=0.018). There was no case of fatty liver and metabolic syndrome in non-obese patients, whereas they were seen in 31.3% and 39.4% of obese PCOS women, respectively. CONCLUSION: Our study showed that metabolic abnormalities are more prevalent in obese PCOS women, but adrenal axis activity that is reflected in higher levels of DHEAS was more commonly pronounced in our non-obese PCOS patients.
35
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Andrea Dunaif, Karen R. Segal, Walter Futterweit et al. · Diabetes · 1989 · 1.9K citations
Medicine, Endocrinology, Gynecology +11
Mechanisms of Insulin Resistance in Aging
Raymond Fink, Orville Kolterman, Jennifer J. Griffin et al. · Journal of Clinical Investigation · 1983 · 552 citations · Full text
Medicine, Endocrinology, Physiology +16